Stay updated on CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Sign up to get notified when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.

Latest updates to the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a minor backend/content management update has been applied. This change reflects a version bump rather than a substantive alteration to the publicly displayed content.SummaryDifference0.0%

- Check17 days agoChange DetectedThe study record timeline was updated with three new dates (2026-07-28, 2026-07-29, 2026-07-30) indicating recent submissions or revisions; older dates (2026-06-29, 2026-07-02, 2026-07-06) were removed from the history.SummaryDifference0.2%

- Check24 days agoChange DetectedA new page revision tag v3.6.4 is added, replacing the previous v3.6.3 and indicating a small metadata update to the page.SummaryDifference0.0%

- Check38 days agoChange DetectedNew update timestamps were added (2026-07-06, 2026-07-02, 2026-06-29) and older timestamps removed (2026-07-01, 2026-06-30, 2026-05-26). These entries reflect administrative updates to the study record rather than substantive changes.SummaryDifference0.2%

- Check45 days agoChange DetectedUpdated the study contact information by replacing Nirali N Shah, M.D. with Sara K Silbert, M.D., including new phone and email details. The page's revision tag was updated from v3.6.2 to v3.6.3.SummaryDifference0.3%

- Check53 days agoChange DetectedThe page now shows a new revision number, v3.6.2, replacing the previous v3.6.0. This indicates an internal update to the page rendering without changing the study information displayed.SummaryDifference0.0%

Stay in the know with updates to CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.